Filing search / Qualigen Therapeutics, Inc. / "Death" / Page 3

8-K

EX-10.15

lbb o9za21xy5ghq

29 May 20

Qualigen Therapeutics Announces Merger Closing

5:03pm

8-K

EX-10.20

x2x5qbnldj5

29 May 20

Qualigen Therapeutics Announces Merger Closing

5:03pm

8-K

EX-10.3

aoiyx

29 May 20

Qualigen Therapeutics Announces Merger Closing

5:03pm

424B3

dqrszj64a

9 Apr 20

Prospectus supplement

9:30am

S-4/A

xlhzn rzgiv6

13 Mar 20

Registration of securities issued in business combination transactions (amended)

5:28pm

S-4/A

EX-10.54

d7z9gt

13 Mar 20

Registration of securities issued in business combination transactions (amended)

5:28pm

S-4

3szw2

4 Feb 20

Registration of securities issued in business combination transactions

6:26am

8-K

EX-2.1

l3n34a6im6ll o1sen

21 Jan 20

Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement

9:20am

8-K

EX-2.2

f2c92f0g f2pv1he

21 Jan 20

Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement

9:20am

425

EX-2.2

xjxtjf9yhid4f2h

21 Jan 20

Business combination disclosure

9:19am

425

EX-2.1

1g3 2ginb1v6

21 Jan 20

Business combination disclosure

9:19am

8-K

EX-10.2

uhms7 ufx

29 May 18

Ritter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial Officer

6:11am

10-Q

EX-10.3

vu0c0q92d xqd2x7r

12 Aug 15

Quarterly report

12:00am